This is a real-world medical entrance exam question, please give the true answer based on the question and selection. Topic name: All India exam, Subject name: Pharmacology
Bictegravir was approved by FDA recently for 
Select and explain. 
A. Cystic fibrosis, B. TB, C. Hypeension, D. HIV
D: HIV
Answer: D: HIV 
Explanation: Bictegravir (an Integrase Inhibitor) is a component of the fixed-dose combination product bictegravir/emtricitabine/tenofovir alafenamide (brand name: Biktarvy), which received marketing approval for the treatment of HIV infection by U.S. Food and Drug Administration in February 2018.